Administration of Purified Human Plasma Cholinesterase Protects Against Cocaine Toxicity in Mice

References

• Mac Donald D. I. Cocaine leads emergency department drug visits. JAMA 1987; 258: 2029
   Google Scholar
• Stewart D. J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 1979; 25: 464–468
   PubMed Web of Science ®Google Scholar
• Jatlow P., Barash P. G., Van Dyke C., Radding J., Byck R. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg 1979; 58: 235–238
   PubMed Web of Science ®Google Scholar
• Lewin N. A., Goldfrank L. R., Hoffman R. S. Cocaine. Goldfrank's Toxicologic Emergencies5th Ed., L. R. Goldfrank, N. E. Flomenbaum, N. A. Lewin, R. S. Weisman, M. A. Howland, R. S. Hoffman. Appleton & Lange, Norwalk, CT 1994; 847–862
   Google Scholar
• Cregler L. L., Mark H. Medical complications of cocaine abuse. N Engl J Med 1986; 315: 1495–1500
   PubMed Web of Science ®Google Scholar
• Anton A. H. Unexpected cocaine‐induced fatalities: a possible cause. Drug Intell Clin Pharm 1988; 22: 914
   PubMedGoogle Scholar
• Cregler L. L. Protracted elimination of cocaine metabolites. Am J Med 1989; 86: 632–633
   Web of Science ®Google Scholar
• Buchanan J. F. Cocaine intoxication. Hosp Phys 1988; 24: 24–29
   Google Scholar
• Ellenhorn M. J., Barceloux D. G. Cocaine. Medical Toxicology ‐ Diagnosis and Treatment of Human Poisoning, M. J. Ellenhorn, D. G. Barceloux. Elsevier Science Publishing Co., New York 1988; 644–661
   Google Scholar
• Lange R. A., Cigarroa R. G., Flores E. D., et al. Potentiation of cocaine‐induced coronary vasoconstriction by beta‐adrenergicblockade. Ann Intern Med 1990; 112: 897–903
   PubMed Web of Science ®Google Scholar
• Hoffman R. S., Henry G. C., Howland M. A., Weisman R. S., Weil L., Goldfrank L. R. Association between life‐threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992; 21: 247–253
   PubMed Web of Science ®Google Scholar
• Hoffman R. S., Henry G. C., Wax P. M., Weisman R. S., Howland M. A., Goldfrank L. R. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther 1992; 263: 698–702
   PubMed Web of Science ®Google Scholar
• Woods J. W. Behavioral effects of cocaine in animals. Cocaine 1977Research Monograph #13, R. C. Peterson, R. C. Stillman. National Institute on Drug Abuse, Rockville, MD 1977; 63–95
   Google Scholar
• Kalow W., Lindsay H. A. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955; 33: 568–574
   PubMedGoogle Scholar
• Foster H. L., Small J. D., Fox J. G. The Mouse in Biomedical Research. Academic Press, New York 1983; Volume 3: 313
   Google Scholar
• Inaba T., Stewart D. J., Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther 1978; 23: 547–552
   PubMed Web of Science ®Google Scholar
• Leighty E. G., Fentiman A. F. Metabolism of cocaine to norcocaine and benzoylecgonine by an in vitro microsomal enzyme system. Res Comm Chem Pathol Pharmacol 1974; 8: 65–74
   PubMedGoogle Scholar
• Stewart D. J., Inaba T., Kalow W. N‐demethylation of cocaine in the rat and in isolated rat hepatocytes: comparison with aminopyrine demethylation. J Pharmacol Exp Ther 1978; 207: 171–177
   PubMed Web of Science ®Google Scholar
• Stewart D. J., Inaba T., Tang B. K., Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977; 20: 1557–1563
   PubMed Web of Science ®Google Scholar
• Dean R. A., Christian C. D., Sample R. H., Bosron W. F. Human liver cocaine esterases: ethanol‐mediated formation of ethylcocaine. FASEB J 1991; 5: 2735–2739
   PubMed Web of Science ®Google Scholar
• Wilson M. C., Bedford J. A., Kibbe A. H., Sam J. A. Comparative pharmacology of norcocaine in M. mulatta and M. fascicularis. Pharmacol Biochem Behav 1978; 9: 141–145
   PubMed Web of Science ®Google Scholar
• Borne R. F., Bedford J. A., Buelke J. L., et al. Biological effects of cocaine derivatives. I: Improved synthesis and pharmacologic evaluation of norcocaine. J Pharm Sci 1977; 66: 119–120
   PubMed Web of Science ®Google Scholar
• Misra A. L., Nayak P. K., Bloch R., Mule S. J. Estimation and disposition of ‘3H’benzoylecgonine and pharmacological activity of some cocaine metabolites. J Pharm Pharmacol 1975; 27: 784–786
   PubMed Web of Science ®Google Scholar
• Just W. W., Hoyer J. The local anesthetic potency of norcocaine, a metabolite of cocaine. Experientia 1977; 33: 70–71
   PubMedGoogle Scholar
• Fish F., Wilson W. D. Excretion of cocaine and its metabolites in man. J Pharm Pharmacol 1969; 21: 1355–1385
   Google Scholar
• Ambre J., Fischman M., Ruo T. I. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol 1984; 8: 23–25
   PubMed Web of Science ®Google Scholar
• Hamilton H. E., Wallace J. E., Shimek E. L., Land P., Harris S. C., Christenson J. G. Cocaine and benzoyl‐ecgonine excretion in humans. J Forensic Sci 1977; 22: 697–707
   PubMed Web of Science ®Google Scholar
• Jeffcoat A. R., Perez‐Reyes M., Hill J. M., Sadler B. M., Cook C. E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 1989; 17: 153–159
   PubMed Web of Science ®Google Scholar
• Spealman R. D., Madras B. K., Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule‐controlled behavior. J Pharmacol Exp Ther 1989; 251: 142–149
   PubMed Web of Science ®Google Scholar
• Madden J. A., Powers R. H. Effect of cocaine and cocaine metabolites on cerebral arteries. in vitro. Life Sci 1990; 47: 1109–1114
   PubMed Web of Science ®Google Scholar
• Herschman Z., Aaron C. Prolongation of cocaine effect. Anesthesiology 1991; 74: 631–632
   PubMed Web of Science ®Google Scholar
• Kambam J., Mets B., Hickman R. M., et al. The effects of inhibition of plasma cholinesterase and hepatic microsomal enzyme activity on cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine blood levels in pigs. J Lab Oin Med 1992; 120: 323–328
   PubMedGoogle Scholar
• Leibman D., Smolen A., Smolen T. N. Strain, sex, and developmental profiles of cocaine metabolizing enzymes in mice. Pharmacol Biochem Behav 1990; 37: 161–165
   PubMed Web of Science ®Google Scholar
• Thompson M. L., Shuster L., Casey F., Kanel G. C. Sex and strain differences in response to cocaine. Biochem Pharmacol 1984; 33: 1299–1307
   PubMed Web of Science ®Google Scholar